Racism is evil. But some companies haven’t gotten the memo and are diving even deeper into racial obsession following Trump’s ...

Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis ...

Industry growth reports; new GF CEO; UVM for mixed signal; power demands explode; EU-US chip collaboration; earnings; S Korea ...

Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current ...

AI can be invaluable for growth and competitive advantage; however, its application requires a critical mass of proprietary, first-party data as fuel.

The biggest impact on vehicles will be on Ford Motor's Lincoln Nautilus and General Motors' Buick Envision. Those crossovers ...

A trust led by Marco Alan Anasetti and Bonnie Faye Anasetti, who are both principals at energy trading firm Columba Energy, ...

Goldman Sachs analyst maintains Buy rating on Uber Technologies Inc with $96 price target. Q4 gross bookings beat estimates ...

Fay, a leader in digital nutritional therapy, announced yesterday a $50 million Series B funding round led by Goldman Sachs ...

Cash-strapped San Francisco is betting on a new way to pay for its fight against a deadly fentanyl crisis: appealing to the ...

In a recent move by 89bio, Inc., the biopharmaceutical company's Compensation Committee has granted 200,000 restricted stock units (RSUs) to Chief Executive Officer Rohan Palekar. This grant, dated ...

Parrell emphasized expected improvements in same-store revenue growth throughout 2025, with acceleration anticipated in the second half. He cited low unemployment among college graduates and tight ...